JSGracia Profile Banner
Jordi Gracia-Sancho Profile
Jordi Gracia-Sancho

@JSGracia

Followers
2K
Following
6K
Media
375
Statuses
2K

Professor in Translational Hepatology @IDIBAPS @UniBern • Scientific Director @CIBEREHD & @LiverSeminars • EiC @Nature_NPJ Gut & Liver • President @ISHSRtweets

Tarragona, Spain
Joined May 2009
Don't wanna be here? Send us removal request.
@JSGracia
Jordi Gracia-Sancho
2 years
🔸What’s the pathophysiology of Portal Hypertension? 🔹Which therapeutic options are available or in the pipeline? 🔸Can we optimize the research in this field? ✅Answer these, and other, questions in our latest review now available @LancetGastroHep 🆓 https://t.co/T5WUoc02HU
4
37
124
@GrupoJovenAEEH
Grupo Joven AEEH
3 days
⏰Recuerda que este jueves por la tarde tenemos lío! "Lo más destacado del Liver Meeting" Hepatólogos 🔝 te resumirán las novedades más destacadas del congreso de la @AASLDtweets 🗓️ 11 de diciembre 🕓 16:00 💻 online 💸 gratis Inscríbete aquí: https://t.co/pxPDKOg56U 👏
1
13
34
@ISHSRtweets
ISHSR
8 days
The Liver Sinusoid Meeting 2026 connects history and science in the iconic Tarraco — capital of the Roman Empire in the 1st century BC. 📢 Call for abstracts is open! Don’t miss the chance to share your work at a landmark event where past & innovation meet. Link in bio
0
2
2
@mromerogomez
Manuel Romero-Gómez
20 days
X Curso Residentes @AEEHLiver ‘Aplicando la #IA en la práctica clínica en #HepatologIA’ IA para mejorar la salud hepática. Desde enfermedades muy prevalentes a las minoritarias, desde big data a la humanización. Que ilusión!! @HospitalUVRocio @unisevilla @sanidadgob @saludand
0
7
15
@JSGracia
Jordi Gracia-Sancho
24 days
Honored to speak at the Annual Congress of @gastromx in beautiful Veracruz. Lectures focused on hepatic vascular pathobiology, fibrosis & portal hypertension. Grateful for the invitation — Mexican hospitality is truly unbeatable 🇲🇽✨
1
4
21
@JSGracia
Jordi Gracia-Sancho
1 month
Great Liver Meeting 2025❗️ 🔹 Ana Martínez & Raül Pastó presenting their works in parallel sessions 🔸 María Andrés explaining her research poster ➕ invited lectures at the Basic Science Simposium & Cell Biology Session 🫶🏼 Proud of the Liver Vascular Biology Team 🫶🏼 #TLM25
0
3
25
@JSGracia
Jordi Gracia-Sancho
1 month
0
0
0
@JSGracia
Jordi Gracia-Sancho
1 month
The Liver Vascular Biology Team (@idibaps & @CIBER_ISCIII) at The Liver Meeting 2025 that starts today — sharing our science in Washington, DC. 👉🏼 Check out the images for an overview of our participation. Excited to catch up with colleagues and friends! #TLM25
1
4
17
@ISHSRtweets
ISHSR
1 month
The Telegraph discovers Tarragona, the host city of the 2026 Liver Sinusoid Meeting. Do not miss this opportunity to enjoy science, friendship and Mediterranean culture! Abstract submission and early registration is open!
Tweet card summary image
telegraph.co.uk
For a seaside location, rich history and terrific food and wine – but far fewer tourists – head to Tarragona
0
2
2
@BavenoCoop
The Baveno Cooperation: an EASL Consortium
2 months
⏳ Just 5 months left for #BavenoVIII! 🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March) 📍 Baveno, Italy 🌐 The event will take place in a hybrid formula — both in person and online. 🧠 Call for abstracts is now open! 🔗 More info at: https://t.co/5tL0wP7mQF 🧵
1
11
12
@JSGracia
Jordi Gracia-Sancho
2 months
Honored to open the 2nd SinergiUS Meeting by @unisevilla sharing insights on sinusoidal communication as a key player and therapeutic target in chronic #liver disease. Thanks to the organizers and friends from the beautiful Seville for the warm hospitality! 💛
0
2
15
@JSGracia
Jordi Gracia-Sancho
2 months
Years of hard work and constant learning finally pay off! 🧠 Our two new papers explore how miRNAs contribute to liver endothelial dysfunction in cirrhosis — and point toward new therapeutic possibilities. Kudos to @laiaajor & @anitabites 🤟🏻
@idibaps
IDIBAPS
2 months
🆕A team from #CLÍNIC-#IDIBAPS describes the role of certain microRNAs in the development of liver cirrhosis These are two studies that open the door to innovative treatments based on the modulation of these microRNAs 👉 https://t.co/qExTMoBlqx
1
5
9
@CIBER_ISCIII
CIBER ISCIII
2 months
Lidera @JSGracia 👏 #CIBEREHD
@idibaps
IDIBAPS
2 months
@hospitalclinic @JSGracia 🆕Un equipo del #CLÍNIC-#IDIBAPS describe el papel de ciertos microARNs en el desarrollo de cirrosis hepática Se trata de dos estudios que abren la puerta a tratamientos innovadores basados ��​en la modulación de estos microARNs 👉 https://t.co/DX7dzfzhEH
0
2
4
@ReibergerThomas
Thomas Reiberger
2 months
Baveno VIII is approaching: March 27-28 next year 2026 ▶️ Register https://t.co/CAKjVtCkbK ▶️ 15-DEC-2025 Early🐦 ▶️ 15-JAN-2026 Abstracts📩 @EASLnews @AASLDtweets @APASLnews @INASL_Liver @BavenoCoop
0
17
47
@ISHSRtweets
ISHSR
2 months
📢 Abstract submission is OPEN for the 23rd Liver Sinusoid Meeting! Join us in beautiful Tarragona, Spain 🇪🇸 (May 23–26, 2026) to celebrate 50 years of ISHSR. 🧬 Submit your abstract by Dec 31, 2025 🗓️ Early registration until Feb 28, 2026 🏨 Book your stay early!
1
3
2
@JSGracia
Jordi Gracia-Sancho
2 months
Fantástico congreso @pharmacologyvlc 🔝 Programa científico 🔝 Actividades sociales 🔝 Organización 💫 Encantados de presentar nuestros trabajos sobre Agonistas de GLP1R en cirrosis (María Andrés, 🥇mejor comunicación) y Nuevos mediadores de disfunción endotelial (Raül Pastó)
0
3
4
@JSGracia
Jordi Gracia-Sancho
2 months
Fantàstic congrés @pharmacologyvlc 🔝 Programa científic 🔝 Activitats socials 🔝 Organització 💫 Encantats de presentar els nostres últims treballs sobre agonistes de GLP1R en cirrosi (María Andrés, 🥇millor comunicació) i Nous mediadors de disfunció endotelial (Raül Pastó)
0
0
1
@JSGracia
Jordi Gracia-Sancho
2 months
Fantastic #LiverGutFibrosis25 days by @pharmacologyvlc 🔝 Scientific program 🔝 Social activities 🔝 Organization 💫 Delighted to present our latests works on GLP1R agonists in CLD (by María Andrés, 🥇best communication) and Novel mediators of LSECs dysfunction (by Raül Pastó)
2
3
11
@JSGracia
Jordi Gracia-Sancho
2 months
Recién regresado de la conferencia @APASLnews sobre enfermedad hepática esteatósica en Tokio 🇯🇵 — un honor hablar sobre el papel de miARNs en la desdiferenciación de las LSEC en enfermedad hepática crónica. Ciencia top, gran hospitalidad y momentos sociales inolvidables!
0
0
1
@JSGracia
Jordi Gracia-Sancho
2 months
Bentornat de la conferència @APASLnews a Tòquio 🇯🇵 sobre la malaltia hepàtica esteatòsica — un honor estar-hi convidat i presentar el paper dels miARNs en la desdiferenciació de les LSEC en malaltia hepàtica crònica. Ciència top, gran hospitalitat i moments socials inoblidables!
1
0
1
@JSGracia
Jordi Gracia-Sancho
2 months
Just back from the @APASLnews Single Topic Conference on Steatotic #Liver Disease in Tokyo 🇯🇵 — honored to be part of it & present about the role of miRNAs in LSEC dedifferentiation in chronic liver disease. Excellent science, warm hospitality, and unforgettable social moments!
1
1
5